Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Enjaymo
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 24
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 78
2022 Revenue in Millions : 24
Growth (%) : 227
LOOKING FOR A SUPPLIER?